Hypertonic solution in severe covid-19 patient: a potential adjuvant therapy

HIGHLIGHTS

• who: Elaine Hatanaka from the Instituto de Ciu00eancias da Atividade Fu00edsica Esportes, Universidade Cruzeiro do Sul, Su00e3o Paulo, Brazil, Seu00e7u00e3o de Produu00e7u00e3o have published the Article: Hypertonic Solution in Severe COVID-19 Patient: A Potential Adjuvant Therapy, in the Journal: (JOURNAL)

SUMMARY

The World Health Organization (WHO) determined the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) as a pandemic in March 2020. COVID-19 patients have also been reported to have superinfections and coinfections with SARS-CoV-2 and a recent meta-analysis found coinfections (19%) and superinfections . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.